Popular Articles

Likelihood Of Placental-Site Trophoblastic Tumors Linked To The Amount Of Time Since Related Pregnancy
An article published Online First and in a future edition of The Lancet discusses the management of a rare condition called placental-site trophoblastic tumors (PSTTs). They are malignant tumors usually presenting months to years after pregnancy. The chances of surviving those tumors are linked to how much time elapsed since the related pregnancy took place. The article is written by Dr Peter Schmid and Professor Michael J Seckl, of the Imperial College NHS Healthcare Trust, London, UK, and colleagues. This paper is a milestone and the first study in thirty years to inform on a complete national experience of the disease. It represents the world"s largest series.
generic viagra online
ZymoGenetics Reports Encouraging Phase 2 Results In Renal Cell Cancer For IL-21 With Nexavar(R)
ZymoGenetics, Inc. (NASDAQ:ZGEN) announced positive final results from a Phase 2 clinical trial in patients receiving 2nd or 3rd line therapy for advanced renal cell carcinoma with the combination of recombinant Interleukin 21 (IL-21) and Nexavar® (sorafenib) tablets. The combination demonstrated considerable clinical benefit, with an overall response rate (as assessed by an independent review) of 21%, a disease control rate of 82%, and progression-free survival (PFS) of 5.7 months in this heavily pretreated population. Results were presented at the American Society of Clinical Oncology meeting.
News of the day
Stroke Rehab: Improving Impaired Attention May Help Patients Recover From Stroke
It may be possible to improve impaired attention after stroke - which could aid recovery - according to research reported in Stroke: Journal of the American Heart Association.
Health Insurance

RCN Responds To New Report Into Nursing Regulation

Responding to the annual report from the Council for Healthcare Regulatory Excellence (CHRE), Dr. Peter Carter, Chief Executive & General Secretary of the Royal College of Nursing (RCN), said: "This report demonstrates that the Nursing and Midwifery Council (NMC) has made some significant improvements over the last year. We welcome much of the new guidance and the reduction in waiting times for fitness to practice hearings. But the CHRE are also right to point to areas where the NMC still need to improve. Our members have raised serious concerns about the consistency and quality of some NMC judgements, and about the balance of the panels which judge nurses. The public must be assured that the people who make judgements about what constitutes acceptable practice have recent clinical experience themselves. "It"s also very worrying that a nurse can still wait over nine months for a fitness to practice hearing. This is not only disruptive for the individual, but it does nothing to increase public or professional confidence in the NMC as an efficient regulator. The RCN will continue to work closely with the NMC to make sure it can offer an efficient service to patients and nurses." Royal College of Nursing


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):